MCLEAN, Va., May 12, 2011 (GLOBE NEWSWIRE) -- Exmovere Holdings, Inc., a biomedical engineering company, recently made changes in its Board of Directors. As announced in its 8-K filings in April, Mr. Bob Kinssies and Dr. Jun Quion were appointed to the company's Board as Directors.
Mr. Kinssies is best known for his time at Microsoft Corporation starting in 1986 where he was involved in that company's explosive growth and development. Bob brings significant supply-chain experience and expertise to Exmovere Holdings Inc. as well as recognized strategic planning, global sourcing and vendor development. As Exmovere approaches global launch of three key products in 2011 – the Chariot, Exmobaby and the Telepath – Mr. Kinssies will be a valuable resource and advisor for the company.
According to David Bychkov, CEO of Exmovere Holding Inc., "We are very fortunate to have Bob serve as a member of Exmovere's Board of Directors. Bob, as a former Microsoft senior manager and the current President/COO of Innovative Solutions Consultants, brings to the Board a wealth of knowledge in dealing with supply chain matters. In addition, his global experience in taking retail products from order to fulfillment enables him to bring a fresh perspective and valuable insights as Exmovere continues to execute on its growth strategy."
Dr. Jun Quion is the Interim Chief Medical Officer of Exmovere, including the company's Clinica subsidiaries. His role at the company will expand as a Director where he will lead the strategy and development of Exmovere's moves into telemedicine. Jun's background includes significant training and practice in cardiology and related medical conditions tied to Exmovere's key target customers and segments. By infusing the company with more direct contact and ties to the medical community worldwide, Exmovere plans to stake out a leading edge position in using technology and human emotion monitoring for medical applications.
Roseanne Luth, President of Luth Research in San Diego and a key company shareholder commented, "Both Bob Kinssies and Dr. Jun Quion as Directors will add to the breadth of Exmovere knowledge as well as propel the growth and success of the company -- Bob through proven supply chain systems as we take our products to market and Dr. Quion through greater emphasis on telemedicine applications to expand the company's offerings."
About Bob Kinssies
Bob has a productive background from Microsoft. He began his career with Microsoft in 1986 and had the unique opportunity of being involved in their explosive growth. He was fortunate to have directed significant supply chain projects at Microsoft. During his 22 year tenure, in many senior management roles, Bob served as an expert, developing world-class businesses and turnkey solutions. He managed a team of over 500 people and numerous partners who brought retail products from order to fulfillment. In 2008, Bob founded Innovative Solutions Consultants where he proactively engages clients to achieve best-in-class results.
About Dr. Jun Quion
As an undergraduate, Dr. Jun Anthony Quion excelled in the Biological Sciences, graduated Magna Cum Laude and was elected member of the Phi Sigma Biological Honor Society and the Honor Society of Phi Kappa Phi. After obtaining his medical degree from the University of the Philippines, he finished his Internal Medicine Internship and Residency at the Baylor College of Medicine in Houston, Texas. While in Baylor, he completed an extra year of training under the supervision of Dr. Antonio Gotto, Jr. with a Fellowship in Lipids and Artherosclerosis. He took further training in Cardiology and Interventional Cardiology at the University of Connecticut – Hartford Hospital Program. He is Board Certified in Internal medicine and Cardiology and is a Fellow of the American College of Cardiology. Dr. Quion is a practicing cardiologist in Northern Virginia and is an active staff member of Inova Fairfax and Fair Oaks Hospitals.
About Exmovere Holdings Inc.
Exmovere Holdings, Inc. is focused on government and consumer applications for healthcare, mobility, and security and the practical applications of the study of human emotion. The Chariot, Exmobaby pajamas, and the Telepath wristwatch are instrumental in the build out of this vision as a solid representation of Exmovere's push into enhancing human mobility, infant safety, and telemedicine. The company plans on continuing along a path of solid and emotional driven design with a product offering that changes the way people look at the world.
The company believes these products will continue to be on the cutting edge and establish paradigm shifts in the markets we serve. Further inquiries into any of our exciting and innovative product offerings or our plans for go-to-market introductions during 2011 should be directed to the contact person listed below.
The Exmovere Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7861
Certain of the above statements contained in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Actual results, events, and circumstances (including future performance, results, and trends) could differ materially from those set forth in such statements due to various factors, risks, and uncertainties, including, but not limited to, risks associated with the company's future growth and operating results, the uncertainty of market acceptance of the company's products, technological change, competitive factors, and general economic conditions. Except as otherwise required to be disclosed in periodic reports required to be filed by companies registered under the Exchange Act by rules of the Securities and Exchange Commission, the company has no duty and undertakes no obligation to update such statements.